Tryp Therapeutics Inc (TRYPF) Corporate Presentation

Corporate Presentation Fall 2021 Product No. of Patients Collaborator Indications Design Data Read Out Next Steps TRPՓ8802 10 Binge eating disorder, hypothalamic obesity, Prader-Willi syndrome Open label with psychotherapy Interim data expected in 2022 IND submitted; begin enrollment in 4Q 2021 WE ARE ON THE CUSP OF INITIATING OUR PHASE 2A CLINICAL TRIAL IN EATING DISORDERS 23 Eating Disorders